0001721484-23-000001.txt : 20231024 0001721484-23-000001.hdr.sgml : 20231024 20231024150610 ACCESSION NUMBER: 0001721484-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231024 DATE AS OF CHANGE: 20231024 EFFECTIVENESS DATE: 20231024 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Longeveron Inc. CENTRAL INDEX KEY: 0001721484 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472174146 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-495525 FILM NUMBER: 231342456 BUSINESS ADDRESS: STREET 1: 1951 NW 7TH AVENUE STREET 2: SUITE 520 CITY: MIAMI STATE: FL ZIP: 33136 BUSINESS PHONE: 305-302-7158 MAIL ADDRESS: STREET 1: 1951 NW 7TH AVENUE STREET 2: SUITE 520 CITY: MIAMI STATE: FL ZIP: 33136 FORMER COMPANY: FORMER CONFORMED NAME: LONGEVERON LLC DATE OF NAME CHANGE: 20171101 D 1 primary_doc.xml X0708 D LIVE 0001721484 Longeveron Inc. 1951 NW 7TH AVENUE SUITE 520 MIAMI FL FLORIDA 33136 305-909-0840 DELAWARE LONGEVERON LLC Corporation true Wa'El Hashad 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Executive Officer Director Joshua M. Hare 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Executive Officer Director Lisa A. Locklear 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Executive Officer Nataliya Agafonova 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Executive Officer Paul Lehr 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Executive Officer Neil E. Hare 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Director Rock Soffer 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Director Douglas Losordo 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Director Cathy Ross 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Director Ursula Ungaro 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Director Khoso Baluch 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Director Jeffrey Pfeffer 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Director Biotechnology Decline to Disclose 06b false 2023-10-13 false true true false 0 H.C. Wainwright & Co., LLC 375 Craig Schwabe 3137679 430 Park Avenue 4TH Floor New York NY NEW YORK 10022 NY NEW YORK false H.C. Wainwright & Co., LLC 375 Charles Worthman 5160596 430 Park Avenue 4TH Floor New York NY NEW YORK 10022 NY NEW YORK false H.C. Wainwright & Co., LLC 375 Michael Vasinkevich 2843810 430 Park Avenue 4TH Floor New York NY NEW YORK 10022 NY NEW YORK false H.C. Wainwright & Co., LLC 375 Noam Rubinstein 4070245 430 Park Avenue 4TH Floor New York NY NEW YORK 10022 NY NEW YORK false 8350001 0 8350001 The offering amount reflects the exercise price due to the Company assuming cash exercise of all warrants issued to the accredited investor and placement agent in the private placement under Rule 506(b). false 1 280000 true 0 In connection with the registered direct offering concurrent with this private placement, the placement agent received $280,000.07, and warrants to purchase up to 169,697 shares of Common Stock exercisable at $2.0625 per share, among other items. 0 false Longeveron Inc. /s/ Wa'el Hashad Wa'el Hashad Chief Executive Officer 2023-10-24